Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C18H21NO3.ClH |
| Molecular Weight | 335.825 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CN1CC[C@@]23[C@H]4CCC(=O)[C@]2(C)OC5=C(O)C=CC(C[C@@H]14)=C35
InChI
InChIKey=IUIZPWPENLRTFZ-RNWHKREASA-N
InChI=1S/C18H21NO3.ClH/c1-17-14(21)6-4-11-12-9-10-3-5-13(20)16(22-17)15(10)18(11,17)7-8-19(12)2;/h3,5,11-12,20H,4,6-9H2,1-2H3;1H/t11-,12+,17-,18-;/m0./s1
Metopon was developed as an analgesic opium derivative. This drug has a high affinity to the mu-opioid receptor and produces antinociception through this receptor. Metopon was available in Canada only in tablet form for oral administration; however, because of the drug addiction, the Drug Addiction Committee recommended its limited use.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| A comparison of the actions of meperidine, Nu-1196, methadone, morphine, Nu-2206, and metopon upon the intestine and uterus. | 1950-07 |
|
| Pharmacology of metopon and other new analgesic opium derivatives. | 1948-11-01 |
|
| METOPON hydrochloride, alcohol-dextrose, dextrose vitamin solutions. | 1948-07 |
|
| Metopon hydrochloride (methyldihydromorphinone hydrochloride). | 1948-01 |
|
| Metopon. | 1947-09 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
9260
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
||
|
NCI_THESAURUS |
C67413
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2110992
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
PRIMARY | |||
|
124-92-5
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
PRIMARY | |||
|
m7497
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID10154184
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
PRIMARY | |||
|
C83964
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
PRIMARY | |||
|
C046877
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
PRIMARY | |||
|
6O34Q1K8M6
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
PRIMARY | |||
|
16057830
Created by
admin on Mon Mar 31 17:34:22 GMT 2025 , Edited by admin on Mon Mar 31 17:34:22 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
